Carlos Iribarren to Skin Neoplasms
This is a "connection" page, showing publications Carlos Iribarren has written about Skin Neoplasms.
Connection Strength
0.108
-
Incidence of malignancy in patients with moderate-to-severe asthma treated with or without omalizumab. J Allergy Clin Immunol. 2014 Sep; 134(3):560-567.e4.
Score: 0.108